• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Comprehensive study to elucidate molecular mechanisms behind intrahepatic cholestasis

Research Project

Project/Area Number 22590746
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionTokai University

Principal Investigator

KAGAWA Tatehiro  東海大学, 医学部, 准教授 (30245469)

Project Period (FY) 2010 – 2012
Project Status Completed (Fiscal Year 2012)
Budget Amount *help
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2012: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2010: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Keywords胆汁酸トランスポーター / 胆汁うっ滞 / 胆汁分泌 / ウルソデオキシコール酸 / 胆汁酸 / トランスポーター / 膜タンパク
Research Abstract

Intrahepatic cholestasis is a difficult-to-treat disease. Although ursodeoxycholic acid has choleretic effect and is widely used to treat cholestasis, molecular mechanisms behind this effect remain unknown. In this study we demonstrated that ursodeoxycholic acid induces choleresis by stabilizing bile salt export pump in the apical membrane.

Report

(4 results)
  • 2012 Annual Research Report   Final Research Report ( PDF )
  • 2011 Annual Research Report
  • 2010 Annual Research Report
  • Research Products

    (33 results)

All 2013 2012 2011 2010 Other

All Journal Article (15 results) (of which Peer Reviewed: 15 results) Presentation (18 results)

  • [Journal Article] Partial splenic embolization using n-butyl cyanoacrylate: intraprocedural evaluation by magnetic resonance imaging2013

    • Author(s)
      Koizumi J, Kagawa T, et al
    • Journal Title

      Eur Radiol

      Volume: 23(5) Pages: 1429-42

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Meloxicam as an adjuvant to peginterferon alfa-2a and ribavirin treatment for genotype 1 chronic hepatitis C: a randomized trial.2013

    • Author(s)
      Tatehiro Kagawa
    • Journal Title

      Hepatol Research

      Volume: 未確定 Issue: 9 Pages: 925-932

    • DOI

      10.1111/hepr.12046

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Carbon Dioxide (CO2) vs Iodinated Contrast Digital Subtraction Angiography during Balloon-occluded Retrograde Transvenous Obliteration (BRTO) Using Foam Sclerosant for Gastric Varices2012

    • Author(s)
      Koizumi J, Kagawa T, et al
    • Journal Title

      J Vasc Interv Radiol

      Volume: 23 Pages: 1453-1459

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Complete Response after Short-Term Sorafenib Treatment in a Patient with Lymph Node Metastasis of Hepatocellular Carcinoma2012

    • Author(s)
      Mizukami H, Kagawa T, et al
    • Journal Title

      Case Rep Oncol

      Volume: 5 Issue: 2 Pages: 380-384

    • DOI

      10.1159/000341259

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Type 1 gastric cancer presenting as protein-losing gastroenteropathy and ball-valve syndrome2012

    • Author(s)
      Hirose S, Kagawa T, et al
    • Journal Title

      Dig Endosc

      Volume: 24 Issue: 1 Pages: 55-55

    • DOI

      10.1111/j.1443-1661.2011.01164.x

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Balloon-occluded retrograde transvenous obliteration of gastric varices: use of CT-guided foam sclerotherapy to optimize technique2012

    • Author(s)
      Koizumi J, Kagawa T, et al(7名).
    • Journal Title

      AJR Am J Roentgenol

      Volume: 199(1) Pages: 200-7

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Weight-based high- and low-dose ribavirin in combination with peginterferon α-2b therapy for genotype 2 chronic hepatitis C: A randomized trial.2012

    • Author(s)
      Kagawa T, et al
    • Journal Title

      Hepatol Res

      Volume: 42(4) Pages: 351-358

    • NAID

      10031144247

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Involvement of multiple elements inFXR-mediated transcriptional activationof FGF192012

    • Author(s)
      Miyata M, Kagawa T, et al
    • Journal Title

      J Steroid Biochem Mol Biol

      Volume: 132(1-2) Pages: 41-47

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Effect of endothelin a receptor antagonist on hepatic hemodynamics in cirrhotic rats. Implications for endothelin-1 in portal hypertension2012

    • Author(s)
      Takashimizu S, Kagawa T, et al
    • Journal Title

      Tokai J Exp Clin Med

      Volume: 36(2) Pages: 37-43

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Weight-based high- and low-dose ribavirin in combination with peginterferon α-2b therapy for genotype 2 chronic hepatitis C: A randomized trial.2012

    • Author(s)
      Tatehiro Kagawa
    • Journal Title

      Hepatol Research

      Volume: 42 Issue: 4 Pages: 351-358

    • DOI

      10.1111/j.1872-034x.2011.00944.x

    • NAID

      10031144247

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] C-arm CT-guided foam sclerotherapy for the treatment of gastric varices2010

    • Author(s)
      Koizumi J, Kagawa T, , et al
    • Journal Title

      J Vasc Interv Radiol

      Volume: 21(10) Pages: 1583-7

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection2010

    • Author(s)
      Kagawa T, et al
    • Journal Title

      Cancer 2010

      Volume: 116 Pages: 3638-44

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Differential Impact of Adherence to Pegylated Interferon and Ribavirin in the Treatment of Genotype 1 High Viral2010

    • Author(s)
      Numata M, Kagawa T, et al
    • Journal Title

      Titer Chronic Hepatitis C 2010

      Volume: 702748 Pages: 1-6

    • DOI

      10.1155/2010/702748

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Long-term effects of antiviral therapy in patients with chronic hepatitis C2010

    • Author(s)
      Kagawa T, Keeffe EB
    • Journal Title

      Hepatitis Research and Treatment 2010

      Volume: 562578 Pages: 1-9

    • DOI

      10.1155/2010/562578

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Journal Article] Ursodeoxycholic acid stabilizes the bile salt export pump in the apical membranein MDCK II cells.

    • Author(s)
      Kagawa T, et al
    • Journal Title

      J Gastroenterol

      Volume: (in press)

    • Related Report
      2012 Final Research Report
    • Peer Reviewed
  • [Presentation] 胆汁うっ滞症におけるABCB11 V444A polymorphismとHLA genotypeの解析2012

    • Author(s)
      鶴谷康太、加川建弘
    • Organizer
      第34回胆汁酸研究会
    • Place of Presentation
      名古屋
    • Year and Date
      2012-12-01
    • Related Report
      2012 Final Research Report
  • [Presentation] 肝内胆汁うっ滞症におけるBSEP SNPの解析.ワークショップ:肝臓における薬物代謝研究の展開2012

    • Author(s)
      加川建弘
    • Organizer
      第48回日本肝臓学会総会
    • Place of Presentation
      金沢
    • Related Report
      2012 Final Research Report
  • [Presentation] Impact of ABCB11 V444A polymorphism and HLA genotype on susceptibility to drug-induced cholestasis in Japan.2012

    • Author(s)
      Tatehiro Kagawa
    • Organizer
      63nd Annual Meeting of the American Association for the Study of Liver Diseases
    • Place of Presentation
      Boston
    • Related Report
      2012 Annual Research Report
  • [Presentation] COX-2 inhibitor enhances the efficacy of peginterferon-alfa 2a and ribavirin combination therapy for chronic hepatitis C.2012

    • Author(s)
      Tatehiro Kagawa
    • Organizer
      63nd Annual Meeting of the American Association for the Study of Liver Diseases
    • Place of Presentation
      Boston
    • Related Report
      2012 Annual Research Report
  • [Presentation] Meloxicam as an adjuvant to peginterferon alfa-2a and ribavirin treatment for genotype 1 hepatitis C: a randomized trial.2012

    • Author(s)
      Tatehiro Kagawa
    • Organizer
      he 10th JSH Single topic conference “Hepatitis C: Best practice based on science”
    • Place of Presentation
      Tokyo
    • Related Report
      2012 Annual Research Report
  • [Presentation] 肝内胆汁うっ滞症におけるBSEP SNPの解析2012

    • Author(s)
      加川建弘
    • Organizer
      第48回日本肝臓学会総会
    • Place of Presentation
      金沢
    • Related Report
      2012 Annual Research Report
  • [Presentation] 当院における薬物性肝障害症例の解析2012

    • Author(s)
      荒瀬吉孝
    • Organizer
      第39回日本肝臓学会東部会
    • Place of Presentation
      東京
    • Related Report
      2012 Annual Research Report
  • [Presentation] 当院における36年間の急性肝不全、遅発性肝不全患者の解析2012

    • Author(s)
      広瀬俊治
    • Organizer
      第39回日本肝臓学会東部会
    • Place of Presentation
      東京
    • Related Report
      2012 Annual Research Report
  • [Presentation] 胆汁酸動態の調節因子であるヒト回腸 FGF19は複数のFXR応答領域を介して転写調節される2011

    • Author(s)
      宮田昌明、畑竜也、加川建弘
    • Organizer
      第33回胆汁酸研究会
    • Place of Presentation
      大阪
    • Year and Date
      2011-11-19
    • Related Report
      2012 Final Research Report
  • [Presentation] UDCAによるbile salt export pump活性化機序の解析2010

    • Author(s)
      加川建弘
    • Organizer
      第32回胆汁酸研究会
    • Place of Presentation
      仙台
    • Year and Date
      2010-11-06
    • Related Report
      2012 Final Research Report
  • [Presentation] Ursodeoxycholic acid activates bile salt export pump stably expressed in MDCK II cells.2010

    • Author(s)
      Tatehiro Kagawa
    • Organizer
      第61回アメリカ肝臓学会
    • Place of Presentation
      ボストン
    • Year and Date
      2010-11-01
    • Related Report
      2010 Annual Research Report
  • [Presentation] ウルソデオキシコール酸による胆汁酸トランスポーター活性化機序の解析2010

    • Author(s)
      加川建弘
    • Organizer
      第6回東日本胆汁酸研究会
    • Place of Presentation
      東京
    • Year and Date
      2010-07-31
    • Related Report
      2012 Final Research Report
  • [Presentation] ウルソデオキシコール酸による胆汁酸トランスポーター活性化機序の解析2010

    • Author(s)
      加川建弘
    • Organizer
      第46回日本肝臓学会総会
    • Place of Presentation
      山形
    • Year and Date
      2010-05-28
    • Related Report
      2010 Annual Research Report
  • [Presentation] Ursodeoxycholic acid activates bile salt export pump stably expressed in MDCK II cells2010

    • Author(s)
      Kagawa T
    • Organizer
      61st Annual Meeting of the American Association for the Study of Liver Diseases
    • Place of Presentation
      Boston, USA
    • Related Report
      2012 Final Research Report
  • [Presentation] 胆汁酸トランスポーターにおける糖鎖修飾の意義 -肝硬変症における胆汁うっ滞との関係-.ワークショップ1(胆汁酸と生体機能調節、疾患との関わり)2010

    • Author(s)
      加川建弘、渡辺勲史、峯徹哉
    • Organizer
      第14回日本肝臓学会大会
    • Place of Presentation
      横浜
    • Related Report
      2012 Final Research Report
  • [Presentation] UDCAによるbile salt export pump活性化機序の解析2010

    • Author(s)
      加川建弘
    • Organizer
      第5回トランスポーター研究会
    • Place of Presentation
      東京
    • Related Report
      2012 Final Research Report
  • [Presentation] UDCAによる胆汁酸トランスポーター活性化機序の解析2010

    • Author(s)
      加川建弘
    • Organizer
      第9回生体機能研究会
    • Place of Presentation
      箱根
    • Related Report
      2012 Final Research Report
  • [Presentation] 肝内胆汁うっ滞症におけるABCB11 V444A polymorphismとHLA genotypeの解析

    • Author(s)
      鶴谷康太
    • Organizer
      第34回胆汁酸研究会
    • Place of Presentation
      名古屋
    • Related Report
      2012 Annual Research Report

URL: 

Published: 2010-11-30   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi